文章：

ARL6IP5在癌症中的双向功能及治疗价值

ARL6IP5 in cancers: bidirectional function and therapeutic value

原文发布日期：2025-04-19 

英文摘要：

ARL6IP5 (ADP-ribosylation-like factor 6 interacting protein 5) plays an important role in a variety of physiological or pathological processes, including in cancers. However, the biological roles of ARL6IP5 in cancers are controversial. In this mini-review, we summarized the current understanding on the role of ARL6IP5 in cancers, particularly in the progression of chronic hepatitis virus-related hepatocellular carcinoma, as well as the potential values of ARL6IP5 in cancer therapy. 

摘要翻译：

ARL6IP5（ADP核糖基化样因子6相互作用蛋白5）在多种生理或病理过程（包括癌症）中发挥重要作用。然而，ARL6IP5在癌症中的生物学作用存在争议。本篇微型综述总结了当前对ARL6IP5在癌症中作用的认识，特别是在慢性肝炎病毒相关肝细胞癌进展中的作用，以及ARL6IP5在癌症治疗中的潜在价值。

原文链接：

ARL6IP5 in cancers: bidirectional function and therapeutic value